Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Androgens and DHEA can help prevent breast cancer and improve health in women.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Skin changes can indicate a risk for breast cancer.

A truncated protein linked to breast cancer may change cell adhesion.